Role of Risk Factors in the Incidence of Multidrug-Resistant Tuberculosis
Keywords:
Multidrug-resistant tuberculosis, resistance, tuberculosis, risk factorsAbstract
Objective: To determine the risk factors that played roles in the incidence of multidrug-resistant tuberculosis (MDR-TB) in such patients. Multidrug-Resistant Tuberculosis is a form of tuberculosis caused by Mycobacterium tuberculosis that is resistant to at least isoniazid and rifampicin.
Methods: This was a case control study to compare MDR-TB to non-MDR-TB pulmonary tuberculosis outpatients in Dr. Hasan Sadikin General Hospital, Bandung on August–September 2014. Fifty MDR-TB outpatients were included as the cases and 50 non-MDR-TB outpatients as controls. Data was collected by questionnaires and patient’s registration forms. Bivariate and multivariate analyses were performed using chi-square test and multiple logistic regression test, with p<0.05 considered significant.
Results: From bivariate analysis, number of previous tuberculosis treatments, regularity of previous treatment, and burden of cost were significant risk factors for developing MDR-TB (p<0.05); while from multivariate analysis, number of previous TB treatments was the only risk factor that played a significant role in the incidence of MDR-TB (OR 24.128 95% CI 6.771-85,976).
Conclusions: Patients and medication factors are risk factors that play roles in the incidence of MDR-TB. The significant risk factor is the number of previous TB treatment.
Keywords: Multidrug-resistant tuberculosis, resistance, risk factors, tuberculosis
DOI: 10.15850/ijihs.v5n2.991
References
WHO. Global Tuberculosis Report 2016. Geneva, Switzerland: WHO; 2016.
Nathanson E, Nunn P, Uplekar M, Floyd K, Jaramillo E, Lönnroth K, et al. MDR tuberculosis—critical steps for prevention and control. N Eng J Med. 2010;363(11):1050–8.
Gandhi NR, Nunn P, Dheda K, Schaaf HS, Zignol M, Soolingen DV, et al. Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis. Lancet. 2010;375(9728):1830–43.
Chiang CY, Centis R, Migliori GB. Drug-resistant tuberculosis: past, present, future. Respirology. 2010;15(3):413–32.
Fauci AS. Multidrug-resistant and extensively drug-resistant tuberculosis: the national institute of allergy and infectious diseases research agenda and recommendations for priority research. J Infect Dis. 2008;197(11):1493–8.
Nofizar D, Nawas A, Burhan E. Identification of risk factors in multidrug resistant tuberculosis. MJI. 2011;60(12):537–45.
Zhao Y, Xu S, Wang L, Chin DP, Wang S, Jiang G, et al. National survey of drug-resistant tuberculosis in China. N Engl J Med. 2012;366(23):2161–70.
Law WS, Yew WW, Chiu Leung C, Kam KM, Tam CM, Chan CK, et al. Risk factors for multidrug-resistant tuberculosis in Hong Kong. Int J Tuberc Lung Dis. 2008;12(9):1065–70.
Sarwani D, Nurlaela S, Isnani ZA. Analisis faktor risiko multidrug resistant tuberculosis (MDR-TB) (Studi Kasus di BP4 Purwokerto). JKM. 2013;8(1):62–8.
Caminero JA. Multidrug-resistant tuberculosis: epidemiology, risk factors and case finding [State of the art series. Drug-resistant tuberculosis. Int J Tuberc Lung Dis. 2010;14(4):382–90.
WHO. Multidrug-resistant tuberculosis in Belarus: the size of the problem and associated risk factors. Bull WHO. 2013;91(1):36–45.
Temple B, Ayakaka I, Ogwang S, Nabanjja H, Kayes S, Nakubulwa S, et al. Rate and amplification of drug resistance among previously-treated patients with tuberculosis in Kampala, Uganda. Clin Infect Dis. 2008;47(9):1126–34.
Barroso EC, Mota RMS, Santos RO, Sousa ALO, Barroso JB, Rodrigues JLN. Risk factors for acquired multidrug-resistant tuberculosis. J Pneumologia. 2003;29(2):89–97.
Jaggarajamma K, Sudha G, Chandrasekaran V, Nirupa C, Thomas A, Santha T, et al. Reasons for non-compliance among patients treated under Revised National Tuberculosis Control Programme (RNTCP), Tiruvallur district, South India. Indian J Tuberc. 2007;54(3):130–5.
Lomtadze N, Aspindzelashvili R, Janjgava M, Mirtskhulava V, Wright A, Blumberg HM, et al. Prevalence and risk factors for multidrug-resistant tuberculosis in the Republic of Georgia: a population-based study. Int J Tuberc Lung Dis. 2009;13(1):68–73.
Hill PC, Stevens W, Hill S, Bah J, Donkor SA, Jallow A, et al. Risk factors for defaulting from tuberculosis treatment: a prospective cohort study of 301 cases in the Gambia. Int J Tuberc Lung Dis. 2005;9(12):1349–54.
Wahab F, Ashraf S, Khan N, Anwar R, Afridi MZ. Risk factors for multi-drug resistant tuberculosis in patients at tertiary care hospital, Peshawar. J College Physicians Surg Pakist. 2009;19(3):162–4.
GarcÃa Vázquez E, Esteban J, De Gorgolas M, Fernández Guerrero ML. Infection by resistant Mycobacterium tuberculosis in a hospital population. A longitudinal study of incidental cases at the Fundacion Jimenez Diaz. Revista Clinica Espanola. 1999;199(9):564–8.
Otero L, Krapp F, Tomatis C, Zamudio C, Matthys F, Gotuzzo E, et al. High prevalence of primary multidrug resistant tuberculosis in persons with no known risk factors. PLOS ONE [serial on the internet]. 2011 Oct [cited 2014 Aug 12];6(10):[about 7p.]. Available from: http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0026276.
Turbawaty DK, Gustiani N, Noviani L, Parwati I. Validity of Mycobacterium tuberculosis Antigens Cocktail: ESAT-6, CFP-10 and MPT64 in Sputum and Cerebrospinal Fluid for Pulmonary Tuberculosis and Tuberculous Meningitis Diagnosis. IJIHS. 2015;3(2):60–5.
Downloads
Published
Issue
Section
License
Authors retain copyright and grant International Journal of Integrated Health Sciences right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to freely share and remix the work with an acknowledgement of the work's authorship and initial publication in International Journal of Integrated Health Sciences.
